Other Species / Isoforms
  ZC3H15 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K27-ac
KEKIIEDktFGLKNK
0 1
ZC3H15 (human) KEKIIEDktFGLKNK K27-ac
ZC3H15 (mouse) KEKIIEDKTFGLKNK K27
ZC3H15 (rat) KEKIIEDKTFGLKNK K27
K27-ub
KEKIIEDktFGLKNK
0 6
ZC3H15 (human) KEKIIEDktFGLKNK K27-ub
ZC3H15 (mouse) KEKIIEDkTFGLKNK K27-ub
ZC3H15 (rat) KEKIIEDKTFGLKNK K27
T28-p
EKIIEDktFGLKNKk
0 1
ZC3H15 (human) EKIIEDktFGLKNKk T28-p
ZC3H15 (mouse) EKIIEDkTFGLKNKK T28
ZC3H15 (rat) EKIIEDKTFGLKNKK T28
K35-ac
tFGLKNKkGAkQQKF
0 1
ZC3H15 (human) tFGLKNKkGAkQQKF K35-ac
ZC3H15 (mouse) TFGLKNKKGAKQQKF K35
ZC3H15 (rat) TFGLKNKKGAKQQKF K35
K38-ac
LKNKkGAkQQKFIkA
0 1
ZC3H15 (human) LKNKkGAkQQKFIkA K38-ac
ZC3H15 (mouse) LKNKKGAKQQKFIkA K38
ZC3H15 (rat) LKNKKGAKQQKFIKA K38
K44-ac
AkQQKFIkAVTHQVk
0 1
ZC3H15 (human) AkQQKFIkAVTHQVk K44-ac
ZC3H15 (mouse) AKQQKFIKAVTHQVK K44
ZC3H15 (rat) AKQQKFIKAVTHQVK K44
K44-ub
AkQQKFIkAVTHQVk
0 6
ZC3H15 (human) AkQQKFIkAVTHQVk K44-ub
ZC3H15 (mouse) AKQQKFIkAVTHQVK K44-ub
ZC3H15 (rat) AKQQKFIKAVTHQVK K44
K51-ub
kAVTHQVkFGQQNPR
0 6
ZC3H15 (human) kAVTHQVkFGQQNPR K51-ub
ZC3H15 (mouse) kAVTHQVKFGQQNPR K51
ZC3H15 (rat) KAVTHQVKFGQQNPR K51
K76-ub
LKKDDKKkELQELNE
0 1
ZC3H15 (human) LKKDDKKkELQELNE K76-ub
ZC3H15 (mouse) LKKDDKKKELQELNE K76
ZC3H15 (rat) LKKDDKKKELQELNE K76
K86-ac
QELNELFkPVVAAQK
0 2
ZC3H15 (human) QELNELFkPVVAAQK K86-ac
ZC3H15 (mouse) QELNELFKPVVAAQk K86
ZC3H15 (rat) QELNELFkPVVAAQK K86-ac
K86-ub
QELNELFkPVVAAQK
0 4
ZC3H15 (human) QELNELFkPVVAAQK K86-ub
ZC3H15 (mouse) QELNELFkPVVAAQk K86-ub
ZC3H15 (rat) QELNELFKPVVAAQK K86
K93
kPVVAAQKIsKGADP
0 1
ZC3H15 (human) kPVVAAQKIsKGADP K93
ZC3H15 (mouse) kPVVAAQkISKGADP K93-ub
ZC3H15 (rat) kPVVAAQKISKGADP K93
S95-p
VVAAQKIsKGADPKS
0 1
ZC3H15 (human) VVAAQKIsKGADPKS S95-p
ZC3H15 (mouse) VVAAQkISKGADPKS S95
ZC3H15 (rat) VVAAQKISKGADPKS S95
S135-p
ERKCEKRsVyIDARD
0 2
ZC3H15 (human) ERKCEKRsVyIDARD S135-p
ZC3H15 (mouse) ERKCEKRSVYIDARD S135
ZC3H15 (rat) ERKCEKRSVYIDARD S135
Y137-p
KCEKRsVyIDARDEE
0 16
ZC3H15 (human) KCEKRsVyIDARDEE Y137-p
ZC3H15 (mouse) KCEKRSVYIDARDEE Y137
ZC3H15 (rat) KCEKRSVYIDARDEE Y137
K147-ub
ARDEELEkDtMDNWD
0 1
ZC3H15 (human) ARDEELEkDtMDNWD K147-ub
ZC3H15 (mouse) ARDEELEKDTMDNWD K147
ZC3H15 (rat) ARDEELEKDTMDNWD K147
T149-p
DEELEkDtMDNWDEK
0 1
ZC3H15 (human) DEELEkDtMDNWDEK T149-p
ZC3H15 (mouse) DEELEKDTMDNWDEK T149
ZC3H15 (rat) DEELEKDTMDNWDEK T149
K157-ac
MDNWDEKkLEEVVNK
0 1
ZC3H15 (human) MDNWDEKkLEEVVNK K157-ac
ZC3H15 (mouse) MDNWDEKKLEEVVNK K157
ZC3H15 (rat) MDNWDEKKLEEVVNK K157
K226-ub
KDKKKEEkEDEIsLE
0 1
ZC3H15 (human) KDKKKEEkEDEIsLE K226-ub
ZC3H15 (mouse) KDKKKEEKEDEIsLE K226
ZC3H15 (rat) KDKKKEEKEDEIsLE K226
S231-p
EEkEDEIsLEDLIER
Upstream
0 11
Treatment
  • rapamycin
ZC3H15 (human) EEkEDEIsLEDLIER S231-p
ZC3H15 (mouse) EEKEDEIsLEDLIER S231-p
ZC3H15 (rat) EEKEDEIsLEDLIER S231-p
K259-ac
LESFLAWkKRKRQEK
0 5
ZC3H15 (human) LESFLAWkKRKRQEK K259-ac
ZC3H15 (mouse) LESFLAWKKRKRQEK K259
ZC3H15 (rat) LESFLAWKKRKRQEK K259
D324-ca
GTGGDEVdDSVsVND
0 1
ZC3H15 (human) GTGGDEVdDSVsVND D324-ca
ZC3H15 (mouse) GTGGDEVDDSMGVND D324
ZC3H15 (rat) GTGGDEVDDSVGVND D324
S328-p
DEVdDSVsVNDIDLS
0 1
ZC3H15 (human) DEVdDSVsVNDIDLS S328-p
ZC3H15 (mouse) DEVDDSMGVNDIDIS G328
ZC3H15 (rat) DEVDDSVGVNDIDLS G328
T348-p
DVDETGItVAsLERF
0 1
ZC3H15 (human) DVDETGItVAsLERF T348-p
ZC3H15 (mouse) DVEETGITVAsVERF T348
ZC3H15 (rat) DVEETGITVASLERF T348
S351-p
ETGItVAsLERFSty
Upstream
0 14
Treatment
  • ischemia
  • nocodazole
ZC3H15 (human) ETGItVAsLERFSty S351-p
ZC3H15 (mouse) ETGITVAsVERFSTY S351-p
ZC3H15 (rat) ETGITVASLERFSTY S351
T357-p
AsLERFStytsDkDE
0 12
ZC3H15 (human) AsLERFStytsDkDE T357-p
ZC3H15 (mouse) AsVERFSTYAPDkDE T357
ZC3H15 (rat) ASLERFSTYAsDKDE T357
Y358-p
sLERFStytsDkDEN
Upstream
0 38
Treatment
  • ephrin_B1
ZC3H15 (human) sLERFStytsDkDEN Y358-p
ZC3H15 (mouse) sVERFSTYAPDkDEN Y358
ZC3H15 (rat) SLERFSTYAsDKDEN Y358
T359-p
LERFStytsDkDENK
0 4
ZC3H15 (human) LERFStytsDkDENK T359-p
ZC3H15 (mouse) VERFSTYAPDkDENK A359
ZC3H15 (rat) LERFSTYAsDKDENK A359
S360-p
ERFStytsDkDENKL
0 18
ZC3H15 (human) ERFStytsDkDENKL S360-p
ZC3H15 (mouse) ERFSTYAPDkDENKL P360
ZC3H15 (rat) ERFSTYAsDKDENKL S360-p
K362
FStytsDKDENKLsE
0 1
ZC3H15 (human) FStytsDKDENKLsE K362
ZC3H15 (mouse) FSTYAPDkDENKLsE K362-ac
ZC3H15 (rat) FSTYAsDKDENKLSE K362
K362-ub
FStytsDkDENKLsE
0 1
ZC3H15 (human) FStytsDkDENKLsE K362-ub
ZC3H15 (mouse) FSTYAPDKDENKLsE K362
ZC3H15 (rat) FSTYAsDKDENKLSE K362
S368-p
DkDENKLsEAsGGRA
0 5
ZC3H15 (human) DkDENKLsEAsGGRA S368-p
ZC3H15 (mouse) DkDENKLsEAsGGLA S368-p
ZC3H15 (rat) DKDENKLSEASGGLA S368
S371-p
ENKLsEAsGGRAENG
0 5
ZC3H15 (human) ENKLsEAsGGRAENG S371-p
ZC3H15 (mouse) ENKLsEAsGGLAENG S371-p
ZC3H15 (rat) ENKLSEASGGLAENG S371
S381-p
RAENGERsDLEEDNE
Upstream
0 31
Treatment
  • metastatic potential
ZC3H15 (human) RAENGERsDLEEDNE S381-p
ZC3H15 (mouse) LAENGERSDLDEDSG S381
ZC3H15 (rat) LAENGERSDLDEDSG S381